Insight Molecular Diagnostics Inc banner

Insight Molecular Diagnostics Inc
LSE:0KCC

Watchlist Manager
Insight Molecular Diagnostics Inc Logo
Insight Molecular Diagnostics Inc
LSE:0KCC
Watchlist
Price: 3.5 USD 8.7% Market Closed
Market Cap: $31.9B

Bankruptcy Probability

Insight Molecular Diagnostics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Probability of Bankruptcy
LOCKED
Unlock

Financial Position

Cash & Short-Term Investments
+
3Y
-1%
5Y
-63%
10Y
+217%
Long-Term Investments
+
3Y
-
5Y
-
10Y
-
Debt
+
3Y
-
5Y
-65%
10Y
+21%

Solvency Ratios

Solvency Ratios Comparison
Insight Molecular Diagnostics Inc Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
US
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
110.3m USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
AbbVie Inc
NYSE:ABBV
471.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
217.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences, Inc
NASDAQ:GILD
179B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.3B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
76.4B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
74.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.2B AUD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
52.4B EUR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Natera Inc
NASDAQ:NTRA
57.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
42.8B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found
Is Insight Molecular Diagnostics Inc at risk of bankruptcy?

Insight Molecular Diagnostics Inc's probability of bankruptcy is Hidden .

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Insight Molecular Diagnostics Inc have?

As of the latest report, Insight Molecular Diagnostics Inc has total debt of 242k USD. This includes both short-term (0 USD) and long-term (242k USD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top